Beijing SL Pharmaceutical Co Ltd Financial Flexibility Index

Latest as of September 2025: 0.24x

Beijing SL Pharmaceutical Co Ltd financial flexibility index. Beijing SL Pharmaceutical Co Ltd (002038) has a Financial Flexibility Index of 0.24x as of September 2025. Free cash flow of CN¥77.90 Million (operating CF CN¥66.55 Million minus capex CN¥11.35 Million) represents 0% of total liabilities (CN¥327.96 Million). See Beijing SL Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

0.24x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥77.90 Million
Operating CF − Capex

Total Liabilities

CN¥327.96 Million
CNY

Capital Expenditures

CN¥11.35 Million
CNY

Financial Flexibility Index of Beijing SL Pharmaceutical Co Ltd (2003–2025)

Financial flexibility index of Beijing SL Pharmaceutical Co Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Beijing SL Pharmaceutical Co Ltd across 23 annual periods. Check Beijing SL Pharmaceutical Co Ltd (002038) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Beijing SL Pharmaceutical Co Ltd Financial Flexibility Index by Year (2003–2025)

Beijing SL Pharmaceutical Co Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Beijing SL Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Beijing SL Pharmaceutical Co Ltd (002038) cash conversion ratio.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 0.51x CN¥450.63 Million CN¥257.66 Million CN¥883.49 Million ▼ -64.5%
2024 1.44x CN¥572.87 Million CN¥225.49 Million CN¥398.37 Million ▼ -0.9%
2023 1.45x CN¥678.56 Million CN¥460.20 Million CN¥467.72 Million ▲ +4.0%
2022 1.40x CN¥553.31 Million CN¥389.82 Million CN¥396.60 Million ▼ -13.6%
2021 1.62x CN¥701.54 Million CN¥464.63 Million CN¥434.23 Million ▼ -1.4%
2020 1.64x CN¥671.79 Million CN¥415.84 Million CN¥410.09 Million ▼ -29.5%
2019 2.32x CN¥938.61 Million CN¥665.83 Million CN¥403.76 Million ▲ +53.3%
2018 1.52x CN¥712.55 Million CN¥485.17 Million CN¥469.73 Million ▼ -29.0%
2017 2.14x CN¥610.37 Million CN¥380.72 Million CN¥285.67 Million ▼ -42.4%
2016 3.71x CN¥561.07 Million CN¥396.86 Million CN¥151.19 Million ▼ -13.2%
2015 4.28x CN¥634.55 Million CN¥504.87 Million CN¥148.40 Million ▼ -4.3%
2014 4.47x CN¥616.02 Million CN¥465.00 Million CN¥137.92 Million ▲ +20.3%
2013 3.71x CN¥456.89 Million CN¥347.41 Million CN¥123.09 Million ▼ -39.6%
2012 6.15x CN¥646.49 Million CN¥398.60 Million CN¥105.17 Million ▲ +2.9%
2011 5.97x CN¥301.64 Million CN¥228.59 Million CN¥50.52 Million ▼ -21.0%
2010 7.55x CN¥281.18 Million CN¥238.13 Million CN¥37.22 Million ▲ +35.5%
2009 5.57x CN¥204.86 Million CN¥174.41 Million CN¥36.75 Million ▼ -33.7%
2008 8.41x CN¥217.93 Million CN¥194.32 Million CN¥25.91 Million ▲ +154.0%
2007 3.31x CN¥114.98 Million CN¥88.36 Million CN¥34.71 Million ▼ -4.2%
2006 3.46x CN¥122.50 Million CN¥57.55 Million CN¥35.41 Million ▼ -37.1%
2005 5.50x CN¥128.72 Million CN¥47.48 Million CN¥23.42 Million ▲ +218.3%
2004 1.73x CN¥49.00 Million CN¥31.26 Million CN¥28.38 Million ▲ +35.1%
2003 1.28x CN¥46.99 Million CN¥30.55 Million CN¥36.78 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities